{"id":"https://openalex.org/W2105453043","doi":"https://doi.org/10.1093/nass/nrn315","title":"Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT","display_name":"Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2105453043","doi":"https://doi.org/10.1093/nass/nrn315","mag":"2105453043","pmid":"https://pubmed.ncbi.nlm.nih.gov/18776534","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2727548"},"language":"en","primary_location":{"id":"doi:10.1093/nass/nrn315","doi":"https://doi.org/10.1093/nass/nrn315","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn315","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/623/3868597/nrn315.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/nass/article-pdf/52/1/623/3868597/nrn315.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084358290","display_name":"H. Saneyoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Saneyoshi","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702, USA","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111101846","display_name":"B. C. Vu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. C. Vu","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063432648","display_name":"Stephen H. Hughes","orcid":"https://orcid.org/0000-0002-9176-4377","observed_orcids":["https://orcid.org/0000-0002-9176-4377"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. H. Hughes","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053352871","display_name":"Paul L. Boyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. L. Boyer","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073716313","display_name":"Stefan G. Sarafianos","orcid":"https://orcid.org/0000-0002-5840-154X","observed_orcids":["https://orcid.org/0000-0002-5840-154X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. G. Sarafianos","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102108516","display_name":"V\u00edctor E. M\u00e1rquez","orcid":"https://orcid.org/0009-0007-9619-8531","observed_orcids":["https://orcid.org/0009-0007-9619-8531"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"V. E. Marquez","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702; 2 HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3 Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"]},{"raw_affiliation_string":"2HIV Drug Resistant Program, Center for Cancer Reserch, NCI-Frederick, Frederick, MD, 21702 USA and 3Department Molecular Microbiology, University of Missouri-Columbia, School of Medicine, Columbia, MO, USA 65212","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I76835614"]},{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5102108516"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I76835614"],"apc_list":null,"apc_paid":null,"fwci":13.8919,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.98245614,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":"1","first_page":"623","last_page":"624"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11748","display_name":"Organophosphorus compounds synthesis","score":0.047600001096725464,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase","display_name":"HIV-1 reverse transcriptase","score":0.9959999918937683},{"id":"https://openalex.org/keywords/active-site-binding","display_name":"active site binding","score":0.460999995470047},{"id":"https://openalex.org/keywords/epichlorohydrin","display_name":"epichlorohydrin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/x-ray-crystallography","display_name":"X-ray crystallography","score":0.7749999761581421},{"id":"https://openalex.org/keywords/antiviral-drug-design","display_name":"antiviral drug design","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.5919828414916992},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5618706345558167},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5360667109489441},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.529510498046875},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.4513954818248749},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.257984459400177},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21824783086776733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17065274715423584},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.07594463229179382}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020134","descriptor_name":"Catalytic Domain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/nass/nrn315","doi":"https://doi.org/10.1093/nass/nrn315","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn315","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/623/3868597/nrn315.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},{"id":"pmid:18776534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18776534","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic acids symposium series (2004)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2727548","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2727548","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Nucleic Acids Symp Ser (Oxf)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/nass/nrn315","doi":"https://doi.org/10.1093/nass/nrn315","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nass/nrn315","pdf_url":"https://academic.oup.com/nass/article-pdf/52/1/623/3868597/nrn315.pdf","source":{"id":"https://openalex.org/S193378857","display_name":"Nucleic Acids Symposium Series","issn_l":"0261-3166","issn":["0261-3166","1746-8272"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleic Acids Symposium Series","raw_type":"journal-article"},"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.5199999809265137,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2755550851","display_name":"Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents","funder_award_id":"Z01BC006174","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2105453043.pdf","grobid_xml":"https://content.openalex.org/works/W2105453043.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2326138377","https://openalex.org/W2000959155","https://openalex.org/W1971766796","https://openalex.org/W2002352762","https://openalex.org/W2065710020","https://openalex.org/W1992394302","https://openalex.org/W3195291682","https://openalex.org/W2046438410","https://openalex.org/W2951896097","https://openalex.org/W1979839180"],"abstract_inverted_index":{"The":[0,29],"conformationally":[1],"locked":[2],"carbocyclic":[3,42],"nucleoside":[4,33,43],"phosphonates":[5,44],"2":[6],"and":[7,9,17,26],"2'":[8],"key":[10],"intermediates":[11],"for":[12],"the":[13,32,53],"synthesis":[14],"of":[15,31,56],"3":[16],"3'":[18],"were":[19,45],"prepared":[20],"from":[21],"a":[22],"chiral":[23],"cyclopentene":[24],"derivative":[25],"epicholorohydrine,":[27],"respectively.":[28],"structure":[30],"precursor":[34],"6":[35],"was":[36],"confirmed":[37],"by":[38],"X-ray":[39],"crystallography.":[40],"These":[41],"designed":[46],"to":[47],"probe":[48],"their":[49],"binding":[50],"interactions":[51],"at":[52],"active":[54],"site":[55],"HIV-1-RT.":[57]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}